Centro Diagnóstico Boris Berenstein has been acquired by DASA
The Berenstein family has sold Centro Diagnóstico Boris Berenstein (CDBB) to Diagnósticos da America S.A. (DASA).
CDBB is among the most respected and well-known diagnostic imaging services in the Brazilian northeast region, focusing on MRIs, TC scans and ultrasound exams. It has six patient service centers, distributed in four different cities in the Recife metropolitan region.
DASA is one of the leading healthcare companies in Brazil, operating the biggest diagnostics business in LatAm with a nation-wide network of high-complexity hospitals, clinics, oncology centers and other healthcare management services. DASA serves more than 20 million patients every year and has around 40,000 employees and 250,000 hired physicians.
One of Oaklins’ teams in Brazil acted as the exclusive financial advisor to the seller and the management of CDBB in the preparation of the sale process and due diligence, the approach and parallel negotiations with potential buyers, and assisted them until closing.



Boris Berenstein
Former Owner and President, Centro Diagnóstico Boris Berenstein
Talk to the deal team

Denis Salvador Morante
Oaklins Fortezza Partners

Related deals
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.
Learn moreAgar Scientific has been acquired by Calibre Scientific
Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.
Learn moreCooper Consumer Health has sold Stardea to EA Pharma
Cooper Consumer Health has sold Stardea to EA Pharma.
Learn more